In tumour tissues, a higher proportion of integration sites at nucleotides 1000–1200, including the ENH I/X promoter [340/1817 (18.7%) versus 20/290 (6.9%), P < 0.0001], was also found. The gene discussed is PDLIM5; the disease is neoplasm.